Hindalco Tanks 15% On Novelis' Bay Minette Return Guidance; Buy, Sell Or Hold?
Hindalco Tanks 15% On Novelis' Bay Minette Return Guidance; Buy, Sell Or Hold?
Shares of Hindalco Industries tanked 15 per cent to the day's low of Rs 497.50 on the NSE

Hindalco Share Price: Shares of Hindalco Industries tanked 15 per cent to the day’s low of Rs 497.50 on the NSE on Tuesday after its US-based subsidiary Novelis lowered its returns guidance for Bay Minette project to double digits from an earlier mid-teens. Analysts believe that this would result in lower IRR (Internal Rate of Return).

“Fiscal year-to-date 2024 capital expenditures total $960 million, reflects the planned increase in strategic investments in new rolling and recycling capacity under construction,” Novelis, a subsidiary of Hindalco Industries, said.

On Monday, Novelis reported net income at $174 million which was up 81 per cent year-on-year (YoY) though it excluded special items, the company filing said. The adjusted EBITDA was reported at $454 million which was up 33 per cent YoY. The company reported net sales at $3.9 billion for the third quarter of fiscal year 2024, which decreased 6 per cent versus the prior year period driven by lower average aluminum prices as shipments were in line with prior year levels.

What Should Investors Do Now?

Kotak has recommended an ‘Add’ rating on Hindalco Industries for a price target of Rs 535. The brokerage has expressed a surprise on the Novelis—capex front. The December quarter earnings were in line with its estimates.

Novelis’ 3QFY24 adjusted EBITDA came in line with its estimates with the demand outlook improving in America, whereas Europe and Asia remain under pressure. The company has revised the capex outlay upward for its key growth project—greenfield expansion in North America — by 65 per cent to US$4.1 bn and delayed the timeline by one year to end FY2027E. Management has downgraded the return guidance from this project to ‘double digits’ from ‘mid-teens’ earlier. Cost inflation and delay do not impact our explicit earnings forecast until FY2026E, but damage the growth, earnings and return prospects of the company from a 5-year perspective, Nuvama said in a note.

JM Financial has maintained a buy view on the counter for a price target of Rs 610. The stock remains one of its preferred bets.

Novelis reported 3Q adjusted EBITDA of $454 mn which was higher than JM’s estimates of $437 mn. EBITDA outperformance was due to lower-than-expected raw material costs, it said in its stock review note.

The brokerage also highlighted key takeaways from the call which included a revision in its capex guidance for its Bay Minette plant from $2.7-2.8 bn to $4.1 bn, up 52 per cent.

What's your reaction?

Comments

https://terka.info/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!